These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12608539)

  • 1. Structural studies of EDTA-induced fibrillation of salmon calcitonin.
    Seyferth S; Lee G
    Pharm Res; 2003 Jan; 20(1):73-80. PubMed ID: 12608539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal ions as cofactors for aggregation of therapeutic peptide salmon calcitonin.
    Rastogi N; Mitra K; Kumar D; Roy R
    Inorg Chem; 2012 May; 51(10):5642-50. PubMed ID: 22571374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of salmon calcitonin-sodium triphosphate ionic complex for oral delivery.
    Lee HE; Lee MJ; Park CR; Kim AY; Chun KH; Hwang HJ; Oh DH; Jeon SO; Kang JS; Jung TS; Choi GJ; Lee S
    J Control Release; 2010 Apr; 143(2):251-7. PubMed ID: 20026364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluronic F68 enhanced the conformational stability of salmon calcitonin in both aqueous solution and lyophilized solid form.
    Lee TH; Lin SY
    Biopolymers; 2011 Nov; 95(11):785-91. PubMed ID: 21590758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Glycosaminoglycans Promote Fibrillation of Salmon Calcitonin.
    Malmos KG; Bjerring M; Jessen CM; Nielsen EH; Poulsen ET; Christiansen G; Vosegaard T; Skrydstrup T; Enghild JJ; Pedersen JS; Otzen DE
    J Biol Chem; 2016 Aug; 291(32):16849-62. PubMed ID: 27281819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermal stability and conformational structure of salmon calcitonin in the solid and liquid states.
    Lee TH; Cheng WT; Lin SY
    Biopolymers; 2010 Feb; 93(2):200-7. PubMed ID: 19810109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of reversible and nonreversible aqueous-soluble lipidized conjugates of salmon calcitonin.
    Cheng W; Lim LY
    Mol Pharm; 2008; 5(4):610-21. PubMed ID: 18481870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and adsorption performance of a novel bipolar PS-EDTA resin in aqueous phase.
    Yang L; Li Y; Wang L; Zhang Y; Ma X; Ye Z
    J Hazard Mater; 2010 Aug; 180(1-3):98-105. PubMed ID: 20434838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational transitions and fibrillation mechanism of human calcitonin as studied by high-resolution solid-state 13C NMR.
    Kamihira M; Naito A; Tuzi S; Nosaka AY; Saitô H
    Protein Sci; 2000 May; 9(5):867-77. PubMed ID: 10850796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating calcitonin fibrillogenesis: an antiparallel alpha-helical dimer inhibits fibrillation of salmon calcitonin.
    Andreotti G; Motta A
    J Biol Chem; 2004 Feb; 279(8):6364-70. PubMed ID: 14594801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles.
    Umerska A; Corrigan OI; Tajber L
    Int J Pharm; 2014 Dec; 477(1-2):102-12. PubMed ID: 25447822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time.
    Kamgar-Parsi K; Hong L; Naito A; Brooks CL; Ramamoorthy A
    J Biol Chem; 2017 Sep; 292(36):14963-14976. PubMed ID: 28739873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone targeted delivery of salmon calcitonin hydroxyapatite nanoparticles for sublingual osteoporosis therapy (SLOT).
    Kotak DJ; Devarajan PV
    Nanomedicine; 2020 Feb; 24():102153. PubMed ID: 31988038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors.
    Hilton JM; Dowton M; Houssami S; Sexton PM
    J Endocrinol; 2000 Jul; 166(1):213-26. PubMed ID: 10856900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of salmon calcitonin particles for nasal delivery using spray-drying and novel supercritical fluid-assisted spray-drying processes.
    Cho W; Kim MS; Jung MS; Park J; Cha KH; Kim JS; Park HJ; Alhalaweh A; Velaga SP; Hwang SJ
    Int J Pharm; 2015 Jan; 478(1):288-296. PubMed ID: 25445994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR investigations of structural and dynamics features of natively unstructured drug peptide - salmon calcitonin: implication to rational design of potent sCT analogs.
    Rawat A; Kumar D
    J Pept Sci; 2013 Jan; 19(1):33-45. PubMed ID: 23208874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation pathways of salmon calcitonin in aqueous solution.
    Windisch V; DeLuccia F; Duhau L; Herman F; Mencel JJ; Tang SY; Vuilhorgne M
    J Pharm Sci; 1997 Mar; 86(3):359-64. PubMed ID: 9050806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncovalent pegylation by dansyl-poly(ethylene glycol)s as a new means against aggregation of salmon calcitonin.
    Mueller C; Capelle MA; Arvinte T; Seyrek E; Borchard G
    J Pharm Sci; 2011 May; 100(5):1648-62. PubMed ID: 21374604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional differences in intestinal spreading and pH recovery and the impact on salmon calcitonin absorption in dogs.
    Lee YH; Perry BA; Sutyak JP; Stern W; Sinko PJ
    Pharm Res; 2000 Mar; 17(3):284-90. PubMed ID: 10801216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemical stability of salmon calcitonin (sCT) analogues in aqueous solution].
    Yang B; Cai Y; Han Z; Wu L; Ding Z; Zhang Q; Yang S
    Yao Xue Xue Bao; 1998 Aug; 33(8):610-5. PubMed ID: 12016902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.